Bhagiradha Chemicals & Industries profit and loss

Latest FY26

Revenue: ₹536cr+21.7% on FY25
EBITDA: ₹57.1cr+54.7% on FY25
Net profit: ₹18.2cr+31.1% on FY25
EPS: ₹1.40+22.8% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	607	536	440	408	502	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	3.5	2.4	9.3	2.7	1.3
	611	538	450	410	503
	418	340	279	272	337
	22.0	2.3	0.0	0.0	0.4
	−66.8	−7.0	−0.9	−25.7	−24.0
	52.7	49.5	40.7	33.3	29.6
	20.6	17.5	7.1	7.7	5.0
	25.4	20.9	13.9	11.0	9.8
	103	94.2	84.7	84.8	81.8
	575	517	425	383	440
	78.7	57.1	36.9	42.9	77.3
	53.3	36.2	23.1	31.9	67.5
Profit
	36.1	21.1	25.2	26.9	63.8
	36.1	21.1	25.2	26.9	63.8
	6.9	5.2	7.5	5.1	16.7
	1.7	−2.2	3.9	3.6	2.0
	8.6	2.9	11.4	8.7	18.6
	27.5	18.2	13.9	18.2	45.2
	27.5	18.2	13.9	18.2	45.2
	−0.2	−0.1	0.1	0.2	−1.1
	27.3	18.0	14.0	18.5	44.1
Per share
	₹2.12	₹1.40	₹1.14	₹1.75	₹44.35
	₹2.12	₹1.40	₹1.14	₹1.61	₹44.35
Other comprehensive income — detail
	−0.2	−0.1	0.1	—	—
	−0.2	−0.1	0.1	0.2	−1.1
Per share — as-filed variants
	₹2.12	₹1.40	₹1.14	₹1.75	₹44.35
	₹2.12	₹1.40	₹1.14	₹1.61	₹44.35
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	234	201	162	161	189
	38.6%	37.5%	36.9%	39.5%	37.6%
Adjusted (ex-exceptional items) — derived
	36.1	21.1	25.2	26.9	63.8
	27.5	18.2	13.9	18.2	45.2
	₹2.12	₹1.40	₹1.14	₹1.75	₹44.35

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BHAGCHEM₹199.59

Bhagiradha Chemicals & Industries Limited

· Chemicals

Annual Quarterly₹ CrorePeersNACLIND DHANUKA GSPCROP BHARATRAS INSECTICID IPL MOL PUNJABCHEMMcap ₹2,588 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	502.1	407.6	440.5	535.9	607.2
Other Income	1.3	2.7	9.3	2.4	3.5
Total Income	503.4	410.3	449.8	538.3	610.7
Expenses
+ Cost of Materials Consumed	337.0	272.3	279.0	340.0	417.6
+ Purchases of Stock-in-Trade	0.4	0.0	0.0	2.3	22.0
+ Changes in Inventories	-24.0	-25.7	-0.9	-7.0	-66.8
+ Employee Benefit Expense	29.6	33.3	40.7	49.5	52.7
+ Finance Costs	5.0	7.7	7.1	17.5	20.6
+ Depreciation & Amortisation	9.8	11.0	13.9	20.9	25.4
+ Other Expenses	81.8	84.8	84.7	94.2	103.0
Total Expenses	439.6	383.4	424.5	517.2	574.5
EBITDA	77.3	42.9	36.9	57.1	78.7
EBIT	67.5	31.9	23.1	36.2	53.3
Profit
PBT before Exceptional Items	63.8	26.9	25.2	21.1	36.1
Pretax Income	63.8	26.9	25.2	21.1	36.1
+ Current Tax	16.7	5.1	7.5	5.2	6.9
+ Deferred Tax	2.0	3.6	3.9	-2.2	1.7
Tax Expense	18.6	8.7	11.4	2.9	8.6
Net Income	45.2	18.2	13.9	18.2	27.5
+ Net Income — Continuing Ops	45.2	18.2	13.9	18.2	27.5
+ Other Comprehensive Income	-1.1	0.2	0.1	-0.1	-0.2
Total Comprehensive Income	44.1	18.5	14.0	18.0	27.3
Per Share
Basic EPS	44.35	1.75	1.14	1.40	2.12
Diluted EPS	44.35	1.61	1.14	1.40	2.12
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.1	-0.1	-0.2
+ Items NOT to be Reclassified to P&L	-1.1	0.2	0.1	-0.1	-0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	44.35	1.75	1.14	1.40	2.12
Diluted EPS — Continuing Operations	44.35	1.61	1.14	1.40	2.12
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	188.7	161.0	162.3	200.8	234.5
Gross Margin %	37.58	39.50	36.86	37.46	38.62
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	63.8	26.9	25.2	21.1	36.1
Net Income Adj (tax-effected)	45.2	18.2	13.9	18.2	27.5
EPS Adj	44.35	1.75	1.14	1.40	2.12
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	10.4	10.4	13.0	13.0	13.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.